247 related articles for article (PubMed ID: 36531159)
1. NF-κB Signaling in Tumor Pathways Focusing on Breast and Ovarian Cancer.
Devanaboyina M; Kaur J; Whiteley E; Lin L; Einloth K; Morand S; Stanbery L; Hamouda D; Nemunaitis J
Oncol Rev; 2022; 16():10568. PubMed ID: 36531159
[TBL] [Abstract][Full Text] [Related]
2. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
[TBL] [Abstract][Full Text] [Related]
3. NF-κB Signaling in Ovarian Cancer.
Harrington BS; Annunziata CM
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31443240
[TBL] [Abstract][Full Text] [Related]
4. Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy.
Fakhri S; Moradi SZ; Yarmohammadi A; Narimani F; Wallace CE; Bishayee A
Front Oncol; 2022; 12():834072. PubMed ID: 35299751
[TBL] [Abstract][Full Text] [Related]
5. The nuclear factor-kappa B pathway and response to treatment in breast cancer.
Park YH
Pharmacogenomics; 2017 Dec; 18(18):1697-1709. PubMed ID: 29182047
[TBL] [Abstract][Full Text] [Related]
6. Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer.
Nottingham LK; Yan CH; Yang X; Si H; Coupar J; Bian Y; Cheng TF; Allen C; Arun P; Gius D; Dang L; Van Waes C; Chen Z
Oncogene; 2014 Feb; 33(9):1135-47. PubMed ID: 23455325
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA NKILA inhibited angiogenesis of breast cancer through NF-κB/IL-6 signaling pathway.
Luo LH; Rao L; Luo LF; Chen K; Ran RZ; Liu XL
Microvasc Res; 2020 May; 129():103968. PubMed ID: 31862380
[TBL] [Abstract][Full Text] [Related]
8. Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells.
Gaikwad SM; Thakur B; Sakpal A; Singh RK; Ray P
Int J Biochem Cell Biol; 2015 Apr; 61():90-102. PubMed ID: 25681684
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
[TBL] [Abstract][Full Text] [Related]
10. Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer Treatment.
Zeligs KP; Neuman MK; Annunziata CM
Clin Cancer Res; 2016 Sep; 22(17):4302-8. PubMed ID: 27422962
[TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 regulates metastatic capabilities and chemotherapy sensitivity in epithelial ovarian carcinoma via NF-κB pathway.
Lu H; Liu Y; Wang D; Wang L; Zhou H; Xu G; Xie L; Wu M; Lin Z; Yu Y; Li G
Tumour Biol; 2016 Aug; 37(8):11469-77. PubMed ID: 27012551
[TBL] [Abstract][Full Text] [Related]
13. Pro-inflammatory M1 macrophage enhances metastatic potential of ovarian cancer cells through NF-κB activation.
Cho U; Kim B; Kim S; Han Y; Song YS
Mol Carcinog; 2018 Feb; 57(2):235-242. PubMed ID: 29024042
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells.
Rahman KM; Ali S; Aboukameel A; Sarkar SH; Wang Z; Philip PA; Sakr WA; Raz A
Mol Cancer Ther; 2007 Oct; 6(10):2757-65. PubMed ID: 17913854
[TBL] [Abstract][Full Text] [Related]
15. HOTAIR Up-Regulation Activates NF-κB to Induce Immunoescape in Gliomas.
Wang Y; Yi K; Liu X; Tan Y; Jin W; Li Y; Zhou J; Wang H; Kang C
Front Immunol; 2021; 12():785463. PubMed ID: 34887871
[TBL] [Abstract][Full Text] [Related]
16. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK.
Hagemann T; Wilson J; Kulbe H; Li NF; Leinster DA; Charles K; Klemm F; Pukrop T; Binder C; Balkwill FR
J Immunol; 2005 Jul; 175(2):1197-205. PubMed ID: 16002723
[TBL] [Abstract][Full Text] [Related]
17. The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways.
Maroufi NF; Vahedian V; Akbarzadeh M; Mohammadian M; Zahedi M; Isazadeh A; Pouremamali F; Taefehshokr S; Heidari M; Rashidi M; Nouri M
Breast Cancer; 2020 Jul; 27(4):613-620. PubMed ID: 32026267
[TBL] [Abstract][Full Text] [Related]
18. Paris saponin II inhibits human ovarian cancer cell-induced angiogenesis by modulating NF-κB signaling.
Yang M; Zou J; Zhu H; Liu S; Wang H; Bai P; Xiao X
Oncol Rep; 2015 May; 33(5):2190-8. PubMed ID: 25760800
[TBL] [Abstract][Full Text] [Related]
19. CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling.
Dong YL; Kabir SM; Lee ES; Son DS
PLoS One; 2013; 8(12):e83789. PubMed ID: 24376747
[TBL] [Abstract][Full Text] [Related]
20. High Expression of Nuclear Transcription Factor-κB is Associated with Cisplatin Resistance and Prognosis for Ovarian Cancer.
Kan Y; Liu J; Li F
Cancer Manag Res; 2020; 12():8241-8252. PubMed ID: 32982420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
